International journal of methods in psychiatric research · 2025
The Validity and Reliability Study of the Turkish Version of Cognitive Complaints in Bipolar Disorder Rating Assessment.
СтатьяВалидационное исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ince Guliyev Ezgi, Karaca Ozkutuk Gulcan, Cagal Sema, Ozturk Ece Ozlem, Elik Tugay, Akdas Nupelda, Horasan Cem, Cakır Sibel, Direk Nese, Aydemir Omer
Аннотация
OBJECTIVES: The Cognitive Complaints Rating Scale in Bipolar Disorder (COBRA) is a brief self-report measure designed to capture Subjective Cognitive Complaints (SCC) experienced by patients with Bipolar Disorder (BD). This study aimed to translate the 16-item COBRA into Turkish (COBRA-TR) and comprehensively assess its psychometric properties.
METHODS: We recruited 160 participants, consisting of 80 BD patients in remission and 80 controls. The psychometric evaluation included confirmatory factor analysis (CFA), calculation of internal consistency, and examination of divergent and convergent validity through Pearson's correlations with related scales. Statistical analyses were performed using the SPSSv29 and the Jamovi software of R Statistical Package.
RESULTS: The COBRA-TR showed excellent internal consistency (Cronbach α = 0.898) and robust convergent validity, strongly correlating with the Cognitive Failures Questionnaire (r = 0.784; p < 0.001). It demonstrated moderate-to-high correlations with cognitive (r = 0.574; p < 0.001) and global functioning (r = 0.624; p < 0.001), as assessed by the Functioning Assessment Short Test. CFA provided strong support for a unidimensional factor structure. Furthermore, the COBRA-TR successfully differentiated patients from controls. Clinical variables minimally influenced the scale, though it showed weak correlations with subclinical depressive symptoms (r = 0.325; p = 0.003) and working memory performance (r = -0.250; p = 0.002).
CONCLUSION: Our findings highlight that the COBRA-TR is a highly reliable and valid tool, effectively capturing SCC among BD patients. Its brevity, ease of administration, and strong psychometric properties suggest its potential utility as a valuable instrument in both clinical practice and research settings.
METHODS: We recruited 160 participants, consisting of 80 BD patients in remission and 80 controls. The psychometric evaluation included confirmatory factor analysis (CFA), calculation of internal consistency, and examination of divergent and convergent validity through Pearson's correlations with related scales. Statistical analyses were performed using the SPSSv29 and the Jamovi software of R Statistical Package.
RESULTS: The COBRA-TR showed excellent internal consistency (Cronbach α = 0.898) and robust convergent validity, strongly correlating with the Cognitive Failures Questionnaire (r = 0.784; p < 0.001). It demonstrated moderate-to-high correlations with cognitive (r = 0.574; p < 0.001) and global functioning (r = 0.624; p < 0.001), as assessed by the Functioning Assessment Short Test. CFA provided strong support for a unidimensional factor structure. Furthermore, the COBRA-TR successfully differentiated patients from controls. Clinical variables minimally influenced the scale, though it showed weak correlations with subclinical depressive symptoms (r = 0.325; p = 0.003) and working memory performance (r = -0.250; p = 0.002).
CONCLUSION: Our findings highlight that the COBRA-TR is a highly reliable and valid tool, effectively capturing SCC among BD patients. Its brevity, ease of administration, and strong psychometric properties suggest its potential utility as a valuable instrument in both clinical practice and research settings.